Goodyer P R, Lancaster G, Villeneuve M, Scriver C R
Biochim Biophys Acta. 1980 Dec 1;633(2):191-200. doi: 10.1016/0304-4165(80)90405-5.
Mitochondrial 4-aminobutyrate aminotransferase in rat kidney can utilize pyruvate as the acceptor for the amino group of 4-aminobutyrate. Renal 4-aminobutyrate aminotransferase activity at saturating equimolar concentration of 4-aminobutyrate and 5 mM pyruvate is 42.8 +/- 2.5 mumol/g protein per h (mean +/- S.E.M.) or 70% of 4-aminobutyrate aminotransferase activity with equimolar alpha-ketoglutarate. 4-Aminobutyrate aminotransferase in brain does not transaminate with pyruvate. Since pyruvate is an important mitochondrial metabolite in kidney, net disposal of glutamate via the 4-aminobutyrate pathway is possible. The renal 4-aminobutyrate pathway in the rat has other distinctive features when compared with the pathway in rat brain. Most inhibitors of rat neuronal glutamate decarboxylase were ineffective against the renal form of the enzyme, but 20 mM semicarbazide inhibited the latter form by 80% (P < 0.001) in vitro and reduced renal 4-aminobutyrate content by 75% (P < 0.001) in vivo. In the presence of 20 mM semicarbazide, ammoniagenesis by rat renal cortex slices incubated in 1 mM glutamine was inhibited 26% (P < 0.01). Semicarbazide was proportionately less effective (15% inhibition) when ammonia-genesis was stimulated (+243%) in slices prepared from chronically acidotic animals, and was no deterrant to ammoniagenesis when non-acidotic slices were incubated in supraphysiologic concentrations of 10 mM glutamine. We conclude that whereas integrity of the renal 4-aminobutyrate pathway may contribute to glutamate disposal and thus ammoniagenesis under physiologic conditions, the pathway is a passive participant in the overall process of ammoniagenesis.
大鼠肾脏中的线粒体4-氨基丁酸转氨酶可利用丙酮酸作为4-氨基丁酸氨基的受体。在4-氨基丁酸和5 mM丙酮酸饱和等摩尔浓度下,肾脏4-氨基丁酸转氨酶活性为每小时42.8±2.5 μmol/g蛋白质(平均值±标准误),或为等摩尔α-酮戊二酸时4-氨基丁酸转氨酶活性的70%。脑内的4-氨基丁酸转氨酶不能与丙酮酸进行转氨基作用。由于丙酮酸是肾脏中一种重要的线粒体代谢物,通过4-氨基丁酸途径对谷氨酸进行净处理是可能的。与大鼠脑内的途径相比,大鼠肾脏中的4-氨基丁酸途径还有其他独特特征。大多数大鼠神经元谷氨酸脱羧酶抑制剂对肾脏形式的该酶无效,但20 mM氨基脲在体外可抑制后者80%(P<0.001),并使体内肾脏4-氨基丁酸含量降低75%(P<0.001)。在20 mM氨基脲存在下,用1 mM谷氨酰胺孵育的大鼠肾皮质切片的产氨作用受到26%的抑制(P<0.01)。当慢性酸中毒动物制备的切片中刺激产氨(增加243%)时,氨基脲的作用相应减弱(抑制15%),而当非酸中毒切片在10 mM谷氨酰胺的超生理浓度下孵育时,氨基脲对产氨作用没有抑制作用。我们得出结论,虽然肾脏4-氨基丁酸途径的完整性可能有助于在生理条件下处理谷氨酸并因此促进产氨作用,但该途径在产氨的整个过程中是一个被动参与者。